Swiss National Bank Atri Cure, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Atri Cure, Inc. stock. As of the latest transaction made, Swiss National Bank holds 95,100 shares of ATRC stock, worth $3.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,100

Previous 95,100 -0.0%

Holding current value

$3.43 Million

Previous $2.17 Million 23.14%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$19.86 - $29.09 $35,748 - $52,362	1,800 Added 1.93%	95,100 $2.17 Million
Q4 2023 Feb 06, 2024	SELL	$32.99 - $43.25 $346,395 - $454,125	-10,500 Reduced 10.12%	93,300 $3.33 Million
Q3 2023 Nov 08, 2023	BUY	$41.12 - $57.73 $28,784 - $40,411	700 Added 0.68%	103,800 $4.55 Million
Q2 2023 Aug 09, 2023	BUY	$40.44 - $49.6 $315,432 - $386,880	7,800 Added 8.18%	103,100 $5.09 Million
Q1 2023 May 10, 2023	SELL	$35.87 - $47.22 $398,157 - $524,142	-11,100 Reduced 10.43%	95,300 $3.95 Million
Q4 2022 Feb 08, 2023	BUY	$33.48 - $47.45 $70,308 - $99,645	2,100 Added 2.01%	106,400 $4.72 Million
Q3 2022 Nov 09, 2022	BUY	$38.25 - $52.62 $45,900 - $63,144	1,200 Added 1.16%	104,300 $4.08 Million
Q1 2022 May 09, 2022	BUY	$57.43 - $71.39 $424,982 - $528,286	7,400 Added 7.73%	103,100 $6.77 Million
Q3 2021 Nov 08, 2021	BUY	$69.28 - $84.46 $96,992 - $118,243	1,400 Added 1.48%	95,700 $6.66 Million
Q2 2021 Aug 06, 2021	SELL	$64.13 - $80.18 $551,518 - $689,548	-8,600 Reduced 8.36%	94,300 $7.48 Million
Q1 2021 May 07, 2021	BUY	$53.79 - $66.98 $69,927 - $87,074	1,300 Added 1.28%	102,900 $6.74 Million
Q4 2020 Feb 05, 2021	BUY	$34.56 - $57.55 $62,208 - $103,590	1,800 Added 1.8%	101,600 $5.66 Million
Q3 2020 Nov 09, 2020	BUY	$38.36 - $46.91 $57,540 - $70,365	1,500 Added 1.53%	99,800 $3.98 Million
Q2 2020 Aug 05, 2020	BUY	$31.78 - $51.19 $686,448 - $1.11 Million	21,600 Added 28.16%	98,300 $4.42 Million
Q1 2020 May 08, 2020	BUY	$24.49 - $43.84 $26,939 - $48,224	1,100 Added 1.46%	76,700 $2.58 Million
Q4 2019 Feb 06, 2020	BUY	$24.06 - $32.51 $79,398 - $107,283	3,300 Added 4.56%	75,600 $2.46 Million
Q3 2019 Nov 12, 2019	BUY	$23.81 - $32.52 $14,286 - $19,512	600 Added 0.84%	72,300 $1.8 Million
Q2 2019 Aug 02, 2019	BUY	$26.85 - $30.74 $228,225 - $261,290	8,500 Added 13.45%	71,700 $2.14 Million
Q1 2019 May 10, 2019	BUY	$26.38 - $33.34 $166,194 - $210,042	6,300 Added 11.07%	63,200 $1.69 Million
Q1 2018 May 04, 2018	BUY	$15.05 - $21.03 $33,110 - $46,266	2,200 Added 4.02%	56,900 $1.17 Million
Q3 2017 Nov 03, 2017	BUY	$20.0 - $24.23 $1.09 Million - $1.33 Million	54,700	54,700 $1.22 Million

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.67B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Atri Cure, Inc. Transaction History